share_log

Cybin Says CYB003 Showed Clear Incremental Benefit Of Second Dose, Resulting In 4 Out Of 5 Patients In Remission From Their Depression At 6 Weeks

Cybin Says CYB003 Showed Clear Incremental Benefit Of Second Dose, Resulting In 4 Out Of 5 Patients In Remission From Their Depression At 6 Weeks

賽賓說，CYB003 顯示出第二劑的明顯增量益處，導致五分之四的患者在 6 周後抑鬱症得到緩解
Benzinga ·  2023/11/30 07:36

At 6 weeks, incremental MADRS score reductions were seen with 79% of patients in remission from depression after just two doses of CYB003 (12mg).

6 周後，MADRS 評分逐漸降低，79% 的患者僅服用兩劑 CYB003（12mg）即可緩解抑鬱症。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論